Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-12
DOI
10.1038/s41598-019-44447-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities
- (2017) Pegah Golabi et al. MEDICINE
- Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide
- (2017) J.-Y. Lee et al. DIABETES & METABOLISM
- Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
- (2016) Ran Xu Zhu et al. Gut and Liver
- Cohort Profile: The National Health Insurance Service–National Sample Cohort (NHIS-NSC), South Korea
- (2016) Juneyoung Lee et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Hepatocellular carcinoma epidemiology
- (2014) Cristina Bosetti et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Nested case-control studies: advantages and disadvantages
- (2014) P. Sedgwick BMJ-British Medical Journal
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
- (2012) Chia-Hsuin Chang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study
- (2011) R. Ruiter et al. DIABETES CARE
- Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
- (2011) Ping Wang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
- (2010) Manal M. Hassan et al. CANCER
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
- (2010) Brad Q. Starley et al. HEPATOLOGY
- Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
- (2009) Valter Donadon et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Sulphonylureas and cancer: a case–control study
- (2008) Matteo Monami et al. ACTA DIABETOLOGICA
- In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM)
- (2008) Agnieszka Sliwinska et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
- (2008) Asmaa Ibrahim Gomaa et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started